Literature DB >> 9160177

Risk for human immunodeficiency virus (HIV) infection among persons with severe mental illnesses.

M P Carey1, K B Carey, S C Kalichman.   

Abstract

Individuals diagnosed with a severe mental illness are at significantly enhanced risk for infection with the human immunodeficiency virus (HIV). To better understand elevated seroprevalence in this population, we review the research literature that has investigated HIV-related risk behavior among adults who have a severe and persistent mental illness. This review indicates that 54%-74% of adults report that they have been sexually active in the last year with approximately one third reporting two or more partners. Among those who were sexually active, condom use was inconsistent. A significant minority (4%-35%) of adults also reported a history of injection drug use. Overall, the data indicate that the severely mentally ill engage regularly in practices known to involve increased risk for HIV transmission. We introduce and modify Fisher and Fisher's (1992) theoretical model to organize the possible determinants of HIV-related risk taking among severely mentally ill adults, and encourage use of this model in the design of behavioral epidemiological and risk reduction studies. We also identify several methodological challenges to HIV-related research, including problems associated with the use of self-report measures; diagnostic imprecision; and participant recruitment and retention.

Entities:  

Mesh:

Year:  1997        PMID: 9160177     DOI: 10.1016/s0272-7358(97)00019-6

Source DB:  PubMed          Journal:  Clin Psychol Rev        ISSN: 0272-7358


  57 in total

1.  Recent HIV testing among general hospital inpatients with schizophrenia: findings from four New York City sites.

Authors:  J Walkup; D D McAlpine; M Olfson; C Boyer; S Hansell
Journal:  Psychiatr Q       Date:  2000

2.  HIV-related services for persons with severe mental illness: policy and practice in New Hampshire community mental health.

Authors:  M F Brunette; C C Mercer; C L Carlson; S D Rosenberg; B F Lewis
Journal:  J Behav Health Serv Res       Date:  2000-08       Impact factor: 1.505

3.  Understanding HIV-related risk among persons with a severe and persistent mental illness: insights from qualitative inquiry.

Authors:  C M Gordon; M P Carey; K B Carey; S A Maisto; L S Weinhardt
Journal:  J Nerv Ment Dis       Date:  1999-04       Impact factor: 2.254

4.  The HIV Epidemic Among Individuals with Mental Illness in the United States.

Authors:  Sheri D Weiser; William R Wolfe; David R Bangsberg
Journal:  Curr Infect Dis Rep       Date:  2004-10       Impact factor: 3.725

5.  Use of Medicaid data to explore community characteristics associated with HIV prevalence among beneficiaries with schizophrenia.

Authors:  James Walkup; Ayse Akincigil; Donald R Hoover; Michele J Siegel; Shahla Amin; Stephen Crystal
Journal:  Public Health Rep       Date:  2011 Sep-Oct       Impact factor: 2.792

6.  Sexual Risk Reduction for Patients with Mental Illness: Evidence of Efficacy and Reasons for Hope.

Authors:  Michael P Carey
Journal:  Curr Infect Dis Rep       Date:  2005-03       Impact factor: 3.725

7.  Applying a cognitive-behavioral model of HIV risk to youths in psychiatric care.

Authors:  Geri R Donenberg; Rebecca Moss Schwartz; Erin Emerson; Helen W Wilson; Fred B Bryant; Gloria Coleman
Journal:  AIDS Educ Prev       Date:  2005-06

Review 8.  Preventing HIV, eliminating disparities among Hispanics in the United States.

Authors:  Sana Loue
Journal:  J Immigr Minor Health       Date:  2006-10

9.  Improving Knowledge about HIV and AIDS Among Persons with a Severe Mental Illness in India.

Authors:  Prabha S Chandra; V A S Krishna; Michael P Carey
Journal:  Indian J Soc Psychiatry       Date:  2006

10.  Mental health case management as a locus for HIV prevention: results from case-manager focus groups.

Authors:  John A Encandela; Wynne S Korr; Kathleen Hulton; Gary F Koeske; W Dean Klinkenberg; Laura L Otto-Salaj; Anthony J Silvestre; Eric R Wright
Journal:  J Behav Health Serv Res       Date:  2003 Oct-Dec       Impact factor: 1.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.